Table Of Content

10/01/2019 LD-2 Disclosure Form Clerk of the House of Representatives Secretary of the Senate Legislative Resource Center Office of Public Records B-106 Cannon Building 232 Hart Building Washington, DC 20515 Washington, DC 20510 LOBBYING REPORT http://lobbyingdisclosure.house.gov http://www.senate.gov/lobby Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page 1. Registrant Name Organization/Lobbying Firm Self Employed Individual Bayer Corporation (consolidated report) 2. Address Address1 801 Pennsylvania Ave., NW Suite 745 Address2 City WASHINGTON State DC Zip Code 20004 Country USA 3. Principal place of business (if different than line 2) City State Zip Code Country 4a. Contact Name b. Telephone Number c. E-mail 5. Senate ID# Mr. Brian McCullough 2027378900 [email protected] 5632-12 7. Client Name Self Check if client is a state or local government or instrumentality 6. House ID# Bayer Corporation (consolidated report) 312570000 TYPE OF REPORT 8. Year 2018 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31) 9. Check if this filing amends a previously filed version of this report 10. Check if this is a Termination Report Termination Date 11. No Lobbying Issue Activity INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 12. Lobbying 13. Organizations INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were: Less than $5,000 Less than $5,000 $5,000 or more $ $5,000 or more $ 3,420,000.00 Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income from the client (including all payments to the 14. REPORTING Check box to indicate expense accounting method. registrant by any other entity for lobbying activities on behalf of the See instructions for description of options. client). Method A. Reporting amounts using LDA definitions only Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code 7/20/2018 Signature Digitally Signed By: Brian McCullough Date 5:20:29 PM https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=998D6029-7A8E-453B-B777-5D96B143C222&filingTypeID=55 1/13 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code AGR 16. Specific lobbying issues Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. Monitor legislative and administrative action related to the Endangered Species Act and related reforms. Monitor legislative and administrative action related to reauthorization of the farm bill. Monitor legislative and administrative action related to reauthorization of Animal Drug User Fee Act (ADUFA). Monitor legislative and administrative action related to 7 CFR Part 340. Monitor implementation of the National Bioengineered Food Disclosure Law (P.L. 114-216). Various issues related to proposed corporate acquisition. S. 322, Pet and Women Safety Act of 2017. S. 629, Preventing Antibiotic Resistance Act of 2017. S. 1528, Genetically Engineered Salmon Labeling Act. H.R. 909, Pet and Women Safety Act of 2017. H.R. 953, Reducing Regulatory Burdens Act of 2017. H.R. 1029, Pesticide Registration Enhancement Act of 2017. H.R. 3040, Saving Americas Pollinators Act of 2017. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA), U.S. Trade Representative (USTR) 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy James McVaney Ursula Wojciechowski Edward Barron Brian Nagle Lindsay Morris Lucas Tomanelli Peter Stehouwer 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=998D6029-7A8E-453B-B777-5D96B143C222&filingTypeID=55 2/13 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code BUD 16. Specific lobbying issues Monitor legislative and administrative action on appropriations and budget. Monitor legislative and administrative action related to U.S. Department of Agriculture appropriations. S.Con.Res.3, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026. S. 1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. H.R. 1625, Vehicle for Consolidated Appropriations Act, 2018. H.R. 3268, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Brian Nagle James McVaney Edward Barron Ursula Wojciechowski Julie Corcoran Brian McCullough Lucas Tomanelli 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=998D6029-7A8E-453B-B777-5D96B143C222&filingTypeID=55 3/13 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code CPT 16. Specific lobbying issues Monitor legislative and administrative action related to intellectual property protection. 17. House(s) of Congress and Federal agencies Check if None U.S. Trade Representative (USTR) 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Brian Nagle Brian McCullough Julie Corcoran Edward Barron Ursula Wojciechowski 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=998D6029-7A8E-453B-B777-5D96B143C222&filingTypeID=55 4/13 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code HCR 16. Specific lobbying issues Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administrative action related to womens health issues. Monitor legislative and administrative action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to dietary supplements. Monitor legislative and administrative action related to servicing of medical device equipment. Monitor legislative and administrative action related to companion labeling. Monitor legislative and administrative action related to FDA monograph reform and user fees. Monitor legislative and administrative action related to the repeal of the Affordable Care Act. Monitor legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor legislative and administrative action related to FDA enforcement of prescription to over-the-counter switches of medicine. Monitor legislative and administrative action related to allowed purchases under the Supplemental Nutrition Assistance Program (SNAP). Monitor legislative and administrative action related to opioids. Monitor legislative and administrative action related to implementation of H.R. 3204, Drug Quality and Security Act. S. 404, A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments and for granting export certifications. S. 469, Affordable and Safe Prescription Drug Importation Act. S. 934, FDA Reauthorization Act of 2017. S. 2434, Animal Drug and Animal Generic Drug User Fee Amendments Act of 2018. H.R. 749, Lower Drug Costs through Competition Act. H.R. 1628, American Health Care Act of 2017. H.R. 2009, To amend the Federal Food, Drug, and Cosmetic Act to provide clarity with respect to the regulation of diagnostic imaging devices intended for use with contrast agents. H.R. 2118, Medical Device Servicing Safety and Accountability Act. H.R. 2164, Medical Device Safety Act. H.R. 2430, FDA Reauthorization Act of 2017. H.R. 3841, SNAP Vitamin and Mineral Improvement Act of 2017. H.R. 3921, HEALTHY KIDS Act. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA) 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Julie Corcoran Brian Nagle Lindsay Morris Peter Stehouwer Brian McCullough 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=998D6029-7A8E-453B-B777-5D96B143C222&filingTypeID=55 5/13 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code MMM 16. Specific lobbying issues Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to Medicaid policy. H.R. 849, Protecting Seniors Access to Medicare Act of 2017. S. 251, Protecting Medicare for Executive Action Act of 2017. S. 260, Protecting Seniors Access to Medicare Act of 2017. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Julie Corcoran Brian Nagle Lindsay Morris Peter Stehouwer 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=998D6029-7A8E-453B-B777-5D96B143C222&filingTypeID=55 6/13 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code TAR 16. Specific lobbying issues Monitor legislative and administrative action related to Miscellaneous Tariff Bill (MTB) petitions. S. 2108, Miscellaneous Tariff Bill Act of 2017. H.R. 4318, Miscellaneous Tariff Bill Act of 2017. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Brian McCullough Ursula Wojciechowski Edward Barron James McVaney 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=998D6029-7A8E-453B-B777-5D96B143C222&filingTypeID=55 7/13 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code TAX 16. Specific lobbying issues Monitor legislative and federal activity related to tax reform. Monitor legislative and federal activity related to Treasury Regulations proposed under section 385 of the Internal Revenue Code. Monitor legislative and administrative action related to implementation of H.R. 1, Tax Cuts and Jobs Act. S. 85, Restoring Access to Medication Act of 2017. S. 108, Medical Device Access and Innovation Protection Act. H.R. 184, Protect Medical Innovation Act of 2017. H.R. 394, Restoring Access to Medication Act of 2017. H.R. 1268, Veterinary Medicine Loan Repayment Program Enhancement Act. H.R. 4618, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on certain taxes affecting purchases of prescription medication. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Brian McCullough Ursula Wojciechowski Lindsay Morris Peter Stehouwer James McVaney 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=998D6029-7A8E-453B-B777-5D96B143C222&filingTypeID=55 8/13 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code TRD 16. Specific lobbying issues Monitor legislative issues and administrative action related to trade. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative and administrative action related to foreign regulation of chemicals and pesticides. Monitor legislative issues and administrative action related to trade discussions with China, including those related to the ag biotech sector. Monitor legislative and administrative action related to North American Free Trade Agreement renegotiation. Monitor legislative and administrative action related to duty drawbacks. Monitor legislative and administrative action related to European Union regulation of nutritionals, vitamins and minerals, and dietary supplements. Monitor legislative and administrative action related to investigation of Sections 232 and 301 of the Trade Act of 1974. Monitor legislative and administrative action related to the renegotiation of the North American Free Trade Agreement (NAFTA). Monitor legislative and administrative action related to the renegotiation of the United States-Korea Free Trade Agreement (KORUS FTA). 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR), Environmental Protection Agency (EPA), Agriculture - Dept of (USDA), Natl Security Council (NSC), Treasury - Dept of 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Christopher Leahy Brian McCullough Ursula Wojciechowski James McVaney Julie Corcoran Lindsay Morris Lucas Tomanelli 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=998D6029-7A8E-453B-B777-5D96B143C222&filingTypeID=55 9/13 10/01/2019 LD-2 Disclosure Form LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed. 15. General issue area code GOV 16. Specific lobbying issues S. 119, Sunshine for Regulatory Decrees and Settlements Act of 2017. H.R. 469, Sunshine for Regulations and Regulatory Decrees and Settlements Act of 2017. H.R. 1430, Honest and Open New EPA Science Treatment Act of 2017 or the HONEST Act. H.R. 1431, EPA Science Advisory Board Reform Act of 2017. H.R. 4170, Disclosing Foreign Influence Act. S. 951, Regulatory Accountability Act of 2017. S. 1794, HONEST Act. S. 2039, Disclosing Foreign Influence Act. 17. House(s) of Congress and Federal agencies Check if None U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES 18. Name of each individual who acted as a lobbyist in this issue area First Name Last Name Suffix Covered Official Position (if applicable) New Edward Barron Chris Leahy James McVaney Lucas Tomanelli Brian McCullough Ursula Wojciechowski 19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None https://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=998D6029-7A8E-453B-B777-5D96B143C222&filingTypeID=55 10/13